Search by Drug Name or NDC
NDC 70020-1910-01 IXEMPRA Details
IXEMPRA
IXEMPRA is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by R-Pharm US Operating, LLC. The primary component is .
MedlinePlus Drug Summary
Ixabepilone injection is used alone or in combination with capecitabine to treat breast cancer that cannot be treated with other medications. Ixabepilone is in a class of medications called microtubule inhibitors. It works by killing cancer cells.
Related Packages: 70020-1910-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ixabepilone Injection
Product Information
| NDC | 70020-1910 |
|---|---|
| Product ID | 70020-1910_f316ca9e-c6df-3ee3-e053-2995a90a7e67 |
| Associated GPIs | 21500011002120 |
| GCN Sequence Number | 063245 |
| GCN Sequence Number Description | ixabepilone VIAL 15 MG INTRAVEN |
| HIC3 | V3D |
| HIC3 Description | ANTINEOPLASTIC - EPOTHILONES AND ANALOGS |
| GCN | 98998 |
| HICL Sequence Number | 035083 |
| HICL Sequence Number Description | IXABEPILONE |
| Brand/Generic | Brand |
| Proprietary Name | IXEMPRA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ixabepilone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | KIT |
| Route | n/a |
| Active Ingredient Strength | n/a |
| Active Ingredient Units | n/a |
| Substance Name | n/a |
| Labeler Name | R-Pharm US Operating, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022065 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70020-1910-01 (70020191001)
| NDC Package Code | 70020-1910-1 |
|---|---|
| Billing NDC | 70020191001 |
| Package | 1 KIT in 1 PACKAGE, COMBINATION (70020-1910-1) * 15 mg in 1 VIAL, SINGLE-USE * 8 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2007-10-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |